ANTIVIRAL ACTIVITY AND RESISTANCE PROFILE OF PHOSPHAZID-A NOVEL PRODRUG OF AZT
Machado J., Tsoukas C., Salomon H., Krayevesky A., and Wainberg M.A.

DEVELOPMENT OF DRUG RESISTANCE FOLLOWING NUCLEOSIDE TREATMENT OF HIV DISEASE
M.A. Wainberg, M. Gotte, H. Salomon and Y. Quan

THE PHASE I OF THE CLINICAL OF PHOSPHAZID THE NEW REVERSE TRANSCRIPTAZE INHIBITOR
Yurin O., Kravtchenko A., Serebrovskaya L., Golochvastova E., Burova N., Voronin E., Pokrowsky V.

HEMATOLOGIC SAFETY AND TOLERANCE STUDIES OF 3'-azido-2', 3' dideoxythymidine -5'-H- phosphonate, A NUCLEOSIDE ANALOGUE WITH ANTI HIV-1 ACTIVITY
C. Tsoukas, V. Pokrovsky, G. Hatzakis, A. Krayevsky

A DOSE RANGE STUDY OF THE ANTIRETROVIRAL ACTIVITY OF PHOSPHONOVIR
Tsoukas C., Hatzaxis G., Pokrovsky V., Krayevsky A.